CITIC Securities Co., Ltd.
Special Audit Report on the Custody, Management, and Use of Raised Funds of Qingdao Sanbai Shuo Health Technology Co., Ltd. for 2025
CITIC Securities Co., Ltd. (hereinafter referred to as "CITIC Securities" or "this Sponsor") as the continuing supervision institution for the initial public offering of shares of Qingdao Sanbai Shuo Health Technology Co., Ltd. (hereinafter referred to as "Sanbai Shuo" or "the Company"), in accordance with the "Administrative Measures for Securities Issuance and Listing Sponsorship Business," "Supervision Rules for the Management of Raised Funds of Listed Companies," "Stock Listing Rules of Shenzhen Stock Exchange," and "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 13—Sponsorship Business," etc., has audited the custody, management, and use of Sanbai Shuo's raised funds for 2025. The details are as follows:
I. Basic Situation of Raised Funds
(I) Situation of Raised Funds Received
Approved by the China Securities Regulatory Commission's "Approval for the Initial Public Offering of Shares of Qingdao Sanbai Shuo Health Technology Co., Ltd." (Zhengjian Xuke [2022] No. 2054), Qingdao Sanbai Shuo Health Technology Co., Ltd. publicly issued 60,943,979 ordinary shares of RMB (A shares) at a par value of RMB 1 per share and an issue price of RMB 11.17 per share. The total amount of raised funds was RMB 680,744,245.43. After deducting issuance expenses totaling RMB 70,090,350.29, the net amount of raised funds was RMB 610,653,895.14.